Article Details
Retrieved on: 2025-08-20 23:31:08
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
- Roche's trontinemab (91% amyloid clearance) and Eli Lilly's tau-focused pipeline highlight innovation in disease modification and diagnostics.
Article found on: www.ainvest.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here